U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C17H19N.C6H12O7
Molecular Weight 433.4947
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ETIFELMINE GLUCONATE

SMILES

OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.CCC(CN)=C(C1=CC=CC=C1)C2=CC=CC=C2

InChI

InChIKey=HXSORIGWWKXLDZ-IFWQJVLJSA-N
InChI=1S/C17H19N.C6H12O7/c1-2-14(13-18)17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;7-1-2(8)3(9)4(10)5(11)6(12)13/h3-12H,2,13,18H2,1H3;2-5,7-11H,1H2,(H,12,13)/t;2-,3-,4+,5-/m.1/s1

HIDE SMILES / InChI
Gilutensin is a drug that was developed for the treatment of hypotensive circulatory disorders. As there is no information available on the drug since 1970, its development is supposed to be terminated in early phase.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Name Type Language
ETIFELMINE GLUCONATE
Common Name English
1-BUTANAMINE, 2-(DIPHENYLMETHYLENE)-, D-GLUCONATE
Common Name English
2-ETHYL-3,3-DIPHENYL-2-PROPENYLAMINE GLUCONATE
Common Name English
D-GLUCONIC ACID, COMPD. WITH 2-(DIPHENYLMETHYLENE)-1-BUTANAMINE (1:1)
Systematic Name English
GLUCONIC ACID, D-, COMPD. WITH 2-(DIPHENYLMETHYLENE)BUTYLAMINE (1:1)
Common Name English
BUTYLAMINE, 2-(DIPHENYLMETHYLENE)-, D-GLUCONATE
Common Name English
Code System Code Type Description
FDA UNII
44VF23ML3X
Created by admin on Sat Dec 16 08:07:03 GMT 2023 , Edited by admin on Sat Dec 16 08:07:03 GMT 2023
PRIMARY
EPA CompTox
DTXSID20951262
Created by admin on Sat Dec 16 08:07:03 GMT 2023 , Edited by admin on Sat Dec 16 08:07:03 GMT 2023
PRIMARY
PUBCHEM
206726
Created by admin on Sat Dec 16 08:07:03 GMT 2023 , Edited by admin on Sat Dec 16 08:07:03 GMT 2023
PRIMARY
CAS
28599-37-3
Created by admin on Sat Dec 16 08:07:03 GMT 2023 , Edited by admin on Sat Dec 16 08:07:03 GMT 2023
PRIMARY